Psychotic and catatonic disorders secondary to preeclampsia
DOI:
https://doi.org/10.25118/2236-918X-6-1-5Keywords:
Psychotic disorder, catatonia, preeclampsia, pregnancyAbstract
Even though the neurological manifestations of preeclampsia are well described in the literature, little is known about its psychiatric manifestations. We here describe, for the first time according to the authors’ knowledge, the case of a patient admitted with preeclampsia and psychiatric symptoms of psychosis and catatonia. Details of diagnosis and patient management are presented. The report highlights the role of the clinician in considering the possibility of neuropsychiatric
manifestations secondary to pathological obstetric conditions.
Downloads
Metrics
References
Associação Americana de Psiquiatria. Manual Diagnósti co e Estatí sti co de Transtornos Mentais, 4ª edição (DSM-IV-TR). Porto Alegre: Artes Médicas; 2002.
Northoff G. What catatonia can tell us about “topdown” modulati on: a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25:555-77.
Zeeman GG. Neurologic complicati ons of preeclampsia. Semin Perinatol. 2009;33:166-72.
Freitas F. Roti nas em obstetrícia. 4ª ed. Porto Alegre: Artmed; 2001.
Marques R, Braga J, Leite I, Jorge CS. [Neurological involvement in pre-eclampsia/eclampsia: the role of neuroimaging]. Acta Med Port. 1997;10:585-8.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-44.
Spiegel DR, Varnell C Jr. A case of catatonia due to posterior reversible encephalopathy syndrome treated successfully with anti hypertensives and adjuncti ve olanzapine. Gen Hosp Psychiatry. 2011;33:302.e3-5.
Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome : the retrospecti ve Berlin PRES study. J Neurol. 2012;259:155-64.
Quinn DK, Abbott CC. Catatonia aft er cerebral hypoxia: do the usual treatments apply? Psychosomati cs. 2014;55:525-35.
Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s comprehensive textbook of psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014;5:181.
Rossi DJ, Oshima T, Att well D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000;403:316-21.
Stahl SM. Psicofarmacologia: bases neurocientí fi cas e aplicações práti cas. Rio de Janeiro: Guanabara Koogan; 2010.
Carroll BT, Goforth HW, Thomas C, Ahuja N, McDaniel WW, Kraus MF, et al. Review of adjuncti ve glutamate antagonist therapy
in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci. 2007;19:406-12.
Dalmau J, Gleichman AJ, Hughes EH, Rossi JE, Peng X, Lai M, et al. Anti -NMDA-receptor encephaliti s: case series and analysis of the eff ects of anti bodies. Lancet Neurol. 2008;7:1091-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
